68
Views
1
CrossRef citations to date
0
Altmetric
Original Research

Trazodone effects on [3H]-paroxetine and α2-adrenoreceptors in platelets of patients with major depression

, , , , , & show all
Pages 255-259 | Published online: 10 May 2010

References

  • GernerREstabrookWSteuerJJarvikLTreatment of geriatric depression with trazodone, imipramine, and placebo: a double-blind studyJ Clin Psychiatry1980412162207380822
  • RakelREThe greater safety of trazodone over tricyclic antidepressant agents: 5-year experience in the United StatesPsychopathology19872057633321131
  • SchatzbergAFTrazodone: a 5-year review of antidepressant efficacyPsychopathology19872048563321130
  • FabreLFUnited States experience and perspectives with trazodoneClin Neuropharmacol1989121117
  • CarsonCC3rdMinoRDPriapism associated with trazodone therapyJ Urol19881393693703339747
  • KrausRLLiYJovanovskaARengerJJTrazodone inhibits T-type calcium channelsNeuropharmacology20075330831717610910
  • StahlSMEssential Psychopharmacology: Neuroscientific basis and practical applicationsEd. 3New York, NYCambridge University Press2008
  • SchuckitMAUnited States experience with trazodone: a literature reviewPsychopathology19872032383321128
  • PapakostasGIFavaMA meta-analysis of clinical trials comparing the serotonin (5HT)-2 receptor antagonists trazodone and nefazodone with selective serotonin reuptake inhibitors for the treatment of major depressive disorderEur Psychiatry20072244444717418537
  • Correas GómezMAPortillo MartínJAMartín GarcíaBTrazodone-induced priapismActas Urol Esp20002484084211199305
  • GartrellNIncreased libido in women receiving trazodoneAm J Psychiatry19861437817823717405
  • MarazzitiDPsicofarmacoterapia ClinicaEd. 4Roma, ItaliaFioriti editore2006
  • StahlSMThe human platelet. A diagnostic and research tool for the study of biogenic amines in psychiatric and neurologic disordersArch Gen Psychiatry197734509516140632
  • LeschKPWolozinBLMurphyDLRiedererPPrimary structure of the human platelet serotonin uptake: identity with the brain serotonin transporterJ Neurochem199360231923227684072
  • QianYMelikianHERyeDBLeveyAIBlakelyRDIdentification and characterization of antidepressant-sensitive serotonin transporter protein using site-specific antibodiesJ Neurosci199515126112747869097
  • FirstMBSpitzerRLGibbonMWilliamsJBWStructured Clinical Interview for DSM-IV Axis I Disorders-Patient edition (SCID-I/P, Version 2.0, 4 97 revision)New York, NYNew York Biometrics Research, New York State Psychiatric Institute1997
  • HamiltonMA rating scale for depressionJ Neurol Neurosurg Psychiatry196023566214399272
  • CorsanoSStrappaghettiGBarbaroRGiannacciniGBettiLLucacchiniASynthesis of new pyridazinone derivatives and their affinity towards alpha1-alpha2-adrenoceptorsBioorg Med Chem1999793394110400346
  • MarazzitiDRossiAGemignaniADecreased platelet 3H-paroxetine binding in obsessive-compulsive patientsNeuropsychobiology1996341841879121618
  • PetersonGLA simplif ication of the protein assay method of Lowry, et al. which is more generally applicableAnal Biochem197783356366
  • OwensMJMorganWNPlottSJNemeroffCBNeurotransmitter receptor and transporter binding profile of antidepressants and their metabolitesJ Pharmacol Exp Ther1997283130513229400006
  • KatasonowABBrusowOSBeljaewBSThe effect of imipramine and trazodone on the re-uptake of (3H) serotonin by thrombocytes in patients with endogenous depression: changes in antidepressive therapyPsychiatr Neurol Med Psychol198941210217
  • BaumannPClinical pharmacokinetics of citalopram and other selective serotonergic reuptake inhibitors (SSRI)Int Clin Psychopharmacol1992613201431018
  • LawrenceKMKatonaCLAbou-SalehMTPlatelet 5-HT uptake sites, labelled with [3H] paroxetine, in controls and depressed patients before and after treatment with fluoxetine or lofepraminePsychopharmacology (Berl)19941152612647862905
  • BakishDCavazzoniPChudzikJRavindranAHrdinaPDEffects of selective serotonin reuptake inhibitors on platelet serotonin parameters in major depressive disorderBiol Psychiatry1997411841909018388
  • SalleeFRHilalRDoughertyDBeachKNesbittLPlatelet serotonin transporter in depressed children and adolescents: 3H-paroxetine platelet binding before and after sertralineJ Am Acad Child Adolesc Psychiatry1998377777849666634
  • AlvarezJCGluckNArnulfIDecreased platelet serotonin transporter sites and increased platelet inositol triphosphate levels in patients with unipolar depression: effects of clomipramine and fluoxetineClin Pharmacol Ther19996661762410613618
  • Stain-MalmgrenRKhouryAEAberg-WistedtAThamASerotonergic function in major depression and effect of sertraline and paroxetine treatmentInt Clin Psychopharmacol2001169310111236074
  • HrdinaPDBakishDRavindranAChudzikJCavazzoniPLapierreYDPlatelet serotonergic indices in major depression: up-regulation of 5-HT2A receptors unchanged by antidepressant treatmentPsychiatry Res19976673859075272